Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06354491 · ClinicalTrials.gov registry record · NA
An Imaging-based Quantitative Biomarker Assay for NAFLD in Children
A NA study of NAFLD and NASH, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06354491: Active NA study of NAFLD and NASH, sponsored by University of Wisconsin, Madison.
NCT06354491 is a NA study of NAFLD and NASH that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 24 participants, below the 164-participant average among 26 other NAFLD trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06354491, a NA study of NAFLD and NASH, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will validate recently developed Magnetic Resonance Imaging (MRI) and Ultrasound (US) based methods for liver fat quantification in children with obesity and healthy range of body mass index (BMI).
Primary Outcome
Demonstrate the feasibility of MRI- and US-based liver fat quantification in children and address technical challenges that may limit the performance of the proposed techniques in the population of interest.
Interventions
- DEVICE Magnetic Resonance Imaging (MRI)
- DEVICE Ultrasound (US)
Study Locations (1)
Wisconsin
- University of Wisconsin, Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2028-07-01 |
| Phase | NA |
What the registry record for NCT06354491 still lists
NCT06354491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 164-participant average among 26 other NAFLD trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with NAFLD appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT06354491 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06354491 about?
NCT06354491 is a clinical study titled "An Imaging-based Quantitative Biomarker Assay for NAFLD in Children". This study will validate recently developed Magnetic Resonance Imaging (MRI) and Ultrasound (US) based methods for liver fat quantification in children with obesity and healthy range of body mass index (BMI).
What is the current status of trial NCT06354491?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-04-01. Estimated completion is 2028-07-01.
What conditions does trial NCT06354491 study?
This clinical trial studies the following conditions: NAFLD, NASH.
What interventions are being tested in trial NCT06354491?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (DEVICE), Ultrasound (US) (DEVICE).
Who is sponsoring clinical trial NCT06354491?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06354491 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NAFLD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06354491's enrollment target sits among peer trials
24 25th of 26 higher than 2 of 26 other NAFLD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NAFLD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reversal of Lipid-Induced Insulin Resistance
RECRUITING · NA
-
NAFLD Clinical Care Pathway
RECRUITING · NA
-
NASH AMPK Exercise Dosing (AMPED) Trial
RECRUITING · NA
-
Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD
ACTIVE NOT RECRUITING · NA
-
The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study)
COMPLETED · NA
-
Healthy Liver - Healthy Brain
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI